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C
ardiovascular disease (CVD) is the number 
1 cause of death globally.1 An estimated 17.5 
million people died from CVD in 2005 (7.6 
million from coronary heart disease and 7.6 million 
from stroke), representing 30% of all global deaths.2 
Globally, two-thirds of stroke and one-half of ischemic 
heart disease are attributable to nonoptimal blood pres-
sure. Worldwide, nonoptimal blood pressure contributes 
to approximately 12.8% of all deaths (7.1 million) and 
4.4% of all disability-adjusted life years (64.3 million) 
in the year 2000. These proportions are highest in 
more developed countries, such as the United States 
and the United Kingdom.3 Racial and ethnic disparities 
in cardiovascular disease prevalence, treatment, and 
outcomes are well documented in the United States, 
and racial and ethnic differences in hypertension are no 
exception.4-7 Cardiovascular disease accounts for 35% of 
excess overall mortality in US blacks, largely because of 
hypertension.8 In Europe, ethnic differences in hyper-
tension prevalence and morbidity and mortality from 
cardiovascular disease have also been described.9,10
Two articles in this issue of the Annals of Family 
Medicine address ethnic disparities in hypertension 
care and control; each study examines the disparities 
problem from a different vantage point. The study by 
Fiscella and Holt11 quantifi es the impact of racial dif-
ferences in hypertension control on cardiovascular and 
cerebrovascular mortality in the United States using 
NHANES data, a meta-analysis of observational stud-
ies of systolic blood pressure, and a meta-analysis of 
systolic blood pressure treatment trials. The study by 
Millett et al uses survey and electronic medical record 
data from family practices in the United Kingdom to 
examine the impact of a systems-level intervention (pay 
for performance) on reducing racial and ethnic dispari-
ties in the management of hypertension. Both stud-
ies highlight the fact that persons of African descent 
(Caribbean and African blacks and African Americans) 
have a higher prevalence of hypertension than persons 
of European descent (whites) and therefore may be at 
increased risk of cardiovascular disease. Both studies 
compare rates of hypertension control for blacks and 
whites; the Millett et al study also provides comparison 
data for South Asians.
Fiscella and Holt found that a reduction in mean 
systolic blood pressure among blacks to that of whites 
would reduce the annual number of black deaths from 
heart disease by 5,590 and from stroke by 2,190. 
This study contributes greatly to the literature on the 
impact of racial disparities on cardiovascular mortal-
ity and highlights the substantial public health impact 
that reducing disparities in hypertension control in 
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the United States could have. As the authors acknowl-
edge, however, the best strategy for eliminating racial 
and ethnic disparities in hypertension control remains 
elusive. They argue that in the absence of evidence for 
disparities in hypertension treatment or severity, efforts 
should focus on addressing patients’ adherence barriers.
Millet et al12 found that whereas no ethnic dispari-
ties existed in blood pressure measurement, dispari-
ties in medication prescribing and in the achievement 
of blood pressure control persisted despite a major 
investment in quality improvement initiatives, includ-
ing pay for performance. These disparities in control 
were particularly marked in patients with multiple car-
diovascular comorbidities, who arguably may be the 
sickest patients.
What can we learn from these studies on racial and 
ethnic disparities and systems-level interventions to 
reduce disparities? First, it seems clear that racial and 
ethnic disparities in hypertension control are pervasive 
and persistent regardless of whether access to health 
care is provided. In the United Kingdom, which has 
universal access to health care, thus eliminating major 
fi nancial barriers to care for ethnic populations, dis-
parities in care and outcomes persist. Furthermore, 
these disparities persist despite a sustained period 
of investment by the United Kingdom in improving 
health care quality. In the United States, the Veterans 
Affairs (VA) health system is the closest surrogate to a 
universal access environment. In studies conducted in 
the VA system, where access barriers are fewer (includ-
ing access to affordable medications), racial dispari-
ties in hypertension control are reduced but still not 
eliminated.13 It appears, therefore, that while improving 
access to health care is an important and necessary 
step, efforts to eliminate racial and ethnic disparities 
must extend beyond simply improving access.
Second, given that overcoming traditional access 
barriers, such as health insurance and primary care, 
does not eliminate disparities in health outcomes, we 
must seek to understand and address factors that initi-
ate and sustain disparities among those who are in care, 
as well as the more upstream or fundamental causes of 
disparities. Doing so will include a closer examination 
of differences within ethnic groups that contribute to 
blood pressure control. Such an approach may allow us 
to better understand the variability in health practices 
within ethnic groups. We submit that greater effort 
should be directed at understanding positive deviance 
as it relates to racial and ethnic disparities in cardio-
vascular outcomes. Positive deviance is the observation 
that in most settings a few at-risk individuals follow 
uncommon, benefi cial practices and consequently 
experience better outcomes than their neighbors who 
share similar risks.14 Positive deviance approaches can 
be applied for use with existing data sets as a tool for 
understanding and reducing health disparities.15 This 
framework shift in our thinking about disparities may 
prove valuable as we design interventions to improve 
disease outcomes.
Third, there is some evidence that patient adher-
ence contributes to disparities in control of high blood 
pressure. The authors of both articles highlight the 
issue of adherence and acknowledge that their studies 
did not account for variations in adherence to medica-
tions—a factor that undoubtedly affects blood pressure 
control and is known to differ by race and ethnicity. 
Understanding how racial and ethnic disparities in 
adherence contribute to suboptimal hypertension con-
trol is critical for developing and evaluating interven-
tions. Patient adherence to health-supporting behaviors 
(eg, taking their medications as directed, exercising, 
eating a healthy diet, avoiding smoking and illicit 
substance use) and clinician adherence (eg, following 
evidence-based guidelines, intensifying antihyperten-
sive medications as appropriate) are both important 
for optimal blood pressure control. In addition to the 
typical barriers to adherence, for ethnic minorities it 
is important to consider the roles of disparate beliefs 
about health and illness, acceptability of various treat-
ments, issues of trust in health care clinicians, and pre-
vious experiences of unfair or discriminatory treatment 
in health care.16
Even so, focusing solely on individual-level char-
acteristics of either patients or clinicians may not be 
suffi cient to truly understand the multiple determi-
nants of a phenomenon as complex as adherence. 
We need to also examine how aspects of the broader 
social environment (eg, neighborhood or community 
characteristics, social networks, and social support) 
contribute to racial and ethnic disparities in health 
behaviors and outcomes through the use of multilevel 
modeling, social network analyses, and studies that 
use mixed qualitative and quantitative methods. Ulti-
mately, interventions to improve adherence, reduce 
disparities, and improve blood pressure control should 
be targeted at multiple levels (eg, individual patient, 
patient-clinician interaction, health care system, and 
the social environment).
Finally, fundamental questions remain regarding 
the effectiveness of quality improvement initiatives for 
reducing or eliminating racial and ethnic disparities in 
health care and outcomes. Although in theory generic 
quality improvement initiatives should improve care and 
outcomes for all, it is unclear whether those at greatest 
risk, such as ethnic minorities, will benefi t the most. 
Strategies to reduce disparities have targeted individual 
patient factors,17-19 clinician factors,20,21 health systems 
factors,19,22-24 or a combination of these.25-27 Addition-
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ally, performance incentive programs, such as pay for 
performance and public reporting systems, have been 
instituted to improve health care quality and to reduce 
racial and ethnic disparities in care.28,29
Systematic reviews and other studies that examine 
the impact of quality improvement strategies on vari-
ous processes of care and health outcomes, including 
their impact on disparity reduction, have inconclusive 
results.24,28,30 Some studies show that ethnic disparities 
in processes of care can be reduced or eliminated.31,32 
Others show that generic quality improvement pro-
grams reduce ethnic disparities in some processes 
of care, but not necessarily health outcomes.30,33,34 
At least 1 empirical study shows that a major public 
reporting program actually increases disparities.28 Few 
studies specifi cally examine strategies to improve the 
quality of health care for minorities, and even fewer 
examine the reduction of racial disparities as an out-
come.35 A systematic review of the effect of culturally 
tailoring interventions on disparities found that most 
interventions did not actually assess health outcomes, 
and when they did, the effect was marginal.19 In sum-
mary, although the evidence is growing, the particular 
characteristics that make quality improvement pro-
grams successful at reducing disparities, their impact 
on health outcomes and their sustainability over time 
are largely unknown. The defi nitive answer to the 
question of whether quality improvement initiatives for 
reducing or eliminating racial and ethnic disparities in 
health care and outcomes lies in the design of the pro-
grams and the rigor of the evaluation methods.
Together, the articles by Fiscella and Holt and Mil-
let and colleagues in this issue of the Annals of Family 
Medicine are valuable additions to the literature on eth-
nic disparities in health care. They serve as an urgent 
call for clinicians, researchers, health care administra-
tors, social activists, and policy makers in the United 
States and the United Kingdom to work together to 
gain a better understanding about how critical bar-
riers experienced by ethnic minorities within and 
outside the health care system interact and to develop 
intensive and comprehensive strategies to overcome 
them. As we strive to eliminate disparities in care, we 
must realize that disparities in outcomes will persist 
until we address the social and political environments, 
within which health care exists, that perpetuate global 
health disparities.
To read or post commentaries in response to this article, see it 
online at http://www.annfammed.org/cgi/content/full/6/6/486.
Key words: Cardiovascular diseases; health care disparities; accessibility 
of health services; medically underserved area
Submitted September 26, 2008; accepted September 26, 2008.
Funding support: Dr Cooper is supported by a grant from the 
National Heart, Lung, and Blood Institute (K24HL083113).
References
 1. World Health Organization. Cardiovascular diseases [ Web page]. 
2007. http://www.who.int/mediacentre/factsheets/fs317/en/index.
html. 
 2. Mendis S, Lindholm LH, Mancia G, et al. World health organization 
(WHO) and international society of hypertension (ISH) risk predic-
tion charts: assessment of cardiovascular risk for prevention and 
control of cardiovascular disease in low and middle-income coun-
tries. J Hypertens. 2007;25(8):1578-1582.
 3. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, 
Rodgers A. Blood pressure and the global burden of disease 2000. 
part II: estimates of attributable burden. J Hypertens. 2006;24(3):
423-430. 
 4. Smedley BD, Stith AY, Nelson AR, for the Committee on Understand-
ing and Eliminating Rational and Ethnic Disparities in Health Care, 
ed. Unequal Treatment: Confronting Racial and Ethnic Disparities in 
Health Care. Washington, DC: National Academies of Science; 2003.
  5. Barnett E, Halverson J. Local increases in coronary heart disease 
mortality among blacks and whites in the United States, 1985-1995. 
Am J Public Health. 2001;91(9):1499-1506. 
 6. Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in 
hypertension prevalence, awareness, and management. Arch Intern 
Med. 2005;165(18):2098-2104. 
 7. Lillie-Blanton M, Maddox TM, Rushing O, Mensah GA. Disparities 
in cardiac care: rising to the challenge of healthy people 2010. J Am 
Coll Cardiol. 2004;44(3):503-508. 
 8. Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribu-
tion of major diseases to disparities in mortality. N Engl J Med. 
2002;347(20):1585-1592. 
 9. Chaturvedi N, McKeigue PM, Marmot MG. Resting and ambula-
tory blood pressure differences in Afro-Caribbeans and Europeans. 
Hypertension. 1993;22(1):90-96. 
 10. Khattar RS, Swales JD, Senior R, Lahiri A. Racial variation in cardio-
vascular morbidity and mortality in essential hypertension. Heart. 
2000;83(3):267-271. 
 11. Fiscella K, Holt K. Racial disparity in hypertension control: tallying 
the death toll. Ann Fam Med. 2008;6(6):497-502.
 12. Millett C, Gray J, Bottle A, Majeed A. Ethnic disparities in blood 
pressure management in patients with hypertension after the intro-
duction of pay for performance. Ann Fam Med. 2008;6(6):490-496. 
 13. Rehman SU, Hutchison FN, Hendrix K, Okonofua EC, Egan BM. 
Ethnic differences in blood pressure control among men at vet-
erans affairs clinics and other health care sites. Arch Intern Med. 
2005;165(9):1041-1047. 
 14. Berggren WL, Wray JD. Positive deviant behavior and nutrition 
education. Food Nutr Bull. 2002;23(4)(Suppl):9-10. 
 15. Walker LO, Sterling BS, Hoke MM, Dearden KA. Applying the con-
cept of positive deviance to public health data: A tool for reducing 
health disparities. Public Health Nurs. 2007;24(6):571-576. 
 16. Cooper LA, Hill MN, Powe NR. Designing and evaluating interven-
tions to eliminate racial and ethnic disparities in health care. J Gen 
Intern Med. 2002;17(6):477-486. 
 17. Bosworth HB, Olsen MK, Neary A, et al. Take control of your blood 
pressure (TCYB) study: A multifactorial tailored behavioral and edu-
cational intervention for achieving blood pressure control. Patient 
Educ Couns. 2008;70(3):338-347. 
 18. Boulware LE, Daumit GL, Frick KD, Minkovitz CS, Lawrence RS, 
Powe NR. An evidence-based review of patient-centered behavioral 
interventions for hypertension. Am J Prev Med. 2001;21(3):221-232. 
ANNALS OF FAMILY MEDICINE ✦ WWW.ANNFAMMED.ORG ✦ VOL. 6, NO. 6 ✦ NOVEMBER/DECEMBER 2008
489
EDITORIALS
 19. Fisher TL, Burnet DL, Huang ES, Chin MH, Cagney KA. Cultural 
leverage: interventions using culture to narrow racial disparities in 
health care. Med Care Res Rev. 2007;64(5)(Suppl):243S-282S. 
 20. Beach MC, Gary TL, Price EG, et al. Improving health care quality 
for racial/ethnic minorities: A systematic review of the best evidence 
regarding provider and organization interventions. BMC Public 
Health. 2006;6:104. 
 21. Beach MC, Price EG, Gary TL, et al. Cultural competence: A system-
atic review of health care provider educational interventions. Med 
Care. 2005;43(4):356-373. 
 22. Becker DM, Yanek LR, Johnson WR Jr, et al. Impact of a commu-
nity-based multiple risk factor intervention on cardiovascular risk in 
black families with a history of premature coronary disease. Circula-
tion. 2005;111(10):1298-1304. 
 23. Brownstein JN, Chowdhury FM, Norris SL, et al. Effectiveness of 
community health workers in the care of people with hypertension. 
Am J Prev Med. 2007;32(5):435-447. 
 24. Peek ME, Cargill A, Huang ES. Diabetes health disparities: A 
systematic review of health care interventions. Med Care Res Rev. 
2007;64(5)(Suppl):101S-156S. 
 25. ClinicalTrials.gov. Patient-physician partnership to improve high 
blood pressure adherence [Web page]. 2008. http://clinicaltrials.
gov/ct2/show/NCT00123045?term=Patient-Physician+Partnership&
rank=1. 
 26. Roumie CL, Elasy TA, Greevy R, et al. Improving blood pres-
sure control through provider education, provider alerts, and 
patient education: A cluster randomized trial. Ann Intern Med. 
2006;145(3):165-175. 
 27. Davis AM, Vinci LM, Okwuosa TM, Chase AR, Huang ES. Cardiovas-
cular health disparities: A systematic review of health care interven-
tions. Med Care Res Rev. 2007;64(5)(Suppl):29S-100S. 
 28. Chien AT, Chin MH, Davis AM, Casalino LP. Pay for performance, 
public reporting, and racial disparities in health care: How are pro-
grams being designed? Med Care Res Rev. 2007;64(5)(Suppl):
283S-304S. 
 29. Petersen LA, Woodard LD, Urech T, Daw C, Sookanan S. Does 
pay-for-performance improve the quality of health care? Ann Intern 
Med. 2006;145(4):265-272. 
 30. Sequist TD, Adams A, Zhang F, Ross-Degnan D, Ayanian JZ. Effect 
of quality improvement on racial disparities in diabetes care. Arch 
Intern Med. 2006;166(6):675-681. 
 31. Asch SM, Kerr EA, Keesey J, et al. Who is at greatest risk for receiv-
ing poor-quality health care? N Engl J Med. 2006;354(11):1147-1156. 
 32. Ma J, Stafford RS. Quality of US outpatient care: Tempo-
ral changes and racial/ethnic disparities. Arch Intern Med. 
2005;165(12):1354-1361. 
 33. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Trends in the 
quality of care and racial disparities in medicare managed care. N 
Engl J Med. 2005;353(7):692-700. 
 34. Sehgal AR. Impact of quality improvement efforts on race and sex 
disparities in hemodialysis. JAMA. 2003;289(8):996-1000. 
 35. Chin MH, Walters AE, Cook SC, Huang ES. Interventions to reduce 
racial and ethnic disparities in health care. Med Care Res Rev. 
2007;64(5)(Suppl):7S-28S. 
